BPC-157 BPC-157 is a synthetic 15-amino-acid peptide classified as an experimental compound studied for its potential effects on tissue response, cellular protection, and biological repair pathways
Its a short chain of amino acidswhat scientists call a peptideoriginally isolated from human gastric juice
PubMed Heffernan, M.A., Thorburn, A.W., Fam, B., Summers, R., Conway-Campbell, B., Waters, M.J., & Ng, F.M

A Narrative Review of BPC-157 This review found it: Enhances VEGFR2 activity Activates Akt-eNOS pathway Increases nitric oxide production Supports endothelial proliferation and capillary formation Musculoskeletal Repair & Inflammatory Cytokines Emerging Use of BPC-157 in Orthopaedic Sports Medicine Preclinical findings indicate: Enhances growth hormone receptor expression Supports angiogenic signalling pathways Reduces inflammatory cytokine activity Improves structural outcomes in muscle, tendon and ligament injury models Angiogenesis & Antioxidant Pathways Multifunctionality and Possible Medical Application of BPC-157 Findings include: Increased antioxidant protein expression HO-1 and glutathione pathway activation Angiogenic effects in wound healing models Laboratory Stability and Handling Each 10MG vial is supplied in lyophilised form to maintain compound stability during storage and laboratory handling within controlled experimental environments

(2013) demonstrated that intranasal Dihexa administration improved cognitive performance in rodent models of dementia-relevant impairment